Publications by authors named "C I E Scheeren"

Most published prediction models for Coronavirus Disease 2019 (COVID-19) were poorly reported, at high risk of bias, and heterogeneous in model performance. To tackle methodological challenges faced in previous prediction studies, we investigated whether model updating and extending improves mortality prediction, using the Intensive Care Unit (ICU) as a proxy. All COVID-19 patients admitted to seven ICUs in the Euregio-Meuse Rhine during the first pandemic wave were included.

View Article and Find Full Text PDF
Article Synopsis
  • The PRECISe trial aimed to determine if providing critically ill patients on mechanical ventilation with higher protein intake (2.0 g/kg per day) would enhance their quality of life and functional recovery compared to standard protein intake (1.3 g/kg per day).
  • This double-blinded, multicentre trial included patients from 10 hospitals across the Netherlands and Belgium, focusing on those expected to need invasive ventilation for at least three days.
  • Key aspects of the study included random assignment to either the standard or high-protein group, with blinding of all involved personnel, and tracking the primary outcome through health utility scores at specified intervals (30, 90, and 180 days post-randomization).
View Article and Find Full Text PDF
Article Synopsis
  • The PRECISe trial is a randomized controlled study that investigates whether higher enteral protein intake improves recovery in critically ill adults on mechanical ventilation, focusing on primary and secondary health outcomes using a Bayesian analysis approach.
  • The primary outcome evaluates quality of life through the EQ-5D-5L score, along with various secondary outcomes, including walking test performance, handgrip strength, and mortality rates, assessed throughout the study period.
  • The study aims to provide insights into the effects of high protein diets in critically ill patients by applying both weakly informative and more specific priors in its analysis, ensuring robust evaluation of the results.
View Article and Find Full Text PDF

Background: Critically ill patients are subject to severe skeletal muscle wasting during intensive care unit (ICU) stay, resulting in impaired short- and long-term functional outcomes and health-related quality of life. Increased protein provision may improve functional outcomes in ICU patients by attenuating skeletal muscle breakdown. Supporting evidence is limited however and results in great variety in recommended protein targets.

View Article and Find Full Text PDF

Objectives: Many prediction models for coronavirus disease 2019 (COVID-19) have been developed. External validation is mandatory before implementation in the intensive care unit (ICU). We selected and validated prognostic models in the Euregio Intensive Care COVID (EICC) cohort.

View Article and Find Full Text PDF